If the two cytoplasmic actin genes ACTB and ACTG1 are more frequently mutated in hematological malignancies than sequencing screens suggest [12,13,14,15,16,17], this should be apparent from a comparison of the alteration frequency of these two genes in blood cancers relative to other cancer types. This evidence concerns the gene ACTG1 and hematologic disorder.